Obstructive sleep apnoea (OSA) represents a risk for dyslipidaemia. Obstructive respiratory events during rapid eye movement (REM) sleep are more strongly related to the development of hypertension and diabetes than in non-REM. However, the relationship between sleep phases and serum lipid profile is unclear. We aimed to analyse the relationship between obstructive respiratory events in REM and non-REM sleep as well as serum lipid profile.
Polysomnography was performed in 94 adult subjects who did not take any lipid-modifying medications. Fasting venous blood sample was taken the following morning for total cholesterol, triglyceride, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, lipoprotein(a), apoprotein A1 (ApoA1) and for apoprotein B (ApoB) measurements. Lipid profiles were correlated with apnoea–hypopnoea index (AHI) during REM (AHIREM) and non-REM (AHINREM) stages in all subjects. In addition, lipid profiles were compared between REM-dependent OSA patients (AHIREM ≥ 5/h, but AHINREM < 5/h) and control subjects (both AHIREM and AHINREM < 5/h).
AHIREM correlated only with triglyceride concentrations (p = 0.04, Spearman’s rho, ρ = 0.21). In contrast, there was a significant association between AHINREM and triglyceride (p = 0.02, ρ = 0.23), ApoB (p = 0.03, ρ = 0.21), HDL-C (p < 0.01, ρ = − 0.32) as well as ApoA1 levels (p = 0.04, ρ = − 0.21). However, these correlations were not present after adjustment for BMI (all p > 0.05). There was no difference in the lipid profile of REM-dependent OSA subjects and healthy controls (p > 0.05).
Altered serum lipid profile is equally associated with a disturbed REM and non-REM sleep in OSA. Obesity must be considered as a strong covariate when interpreting lipid data in sleep apnoea.
Guan J, Yi H, Zou J, Meng L, Tang X, Zhu H, Yu D, Zhou H, Su K, Yang M, Chen H, Shi Y, Wang Y, Wang J, Yin S, Shanghai Sleep Health Study Research G (2016) Distinct severity stages of obstructive sleep apnoea are correlated with unique dyslipidaemia: large-scale observational study. Thorax 71(4):347–355. https://doi.org/10.1136/thoraxjnl-2015-207403 CrossRefPubMedPubMedCentral
Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Z, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WM, Vlachopoulos C, Wood DA, Zamorano JL (2016) 2016 ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 253:281–344. https://doi.org/10.1016/j.atherosclerosis.2016.08.018 CrossRefPubMed
Wu WT, Tsai SS, Shih TS, Lin MH, Chou TC, Ting H, Wu TN, Liou SH (2015) The association between obstructive sleep apnea and metabolic markers and lipid profiles. PLoS ONE 10(6):e0130279. https://doi.org/10.1371/journal.pone.0130279 CrossRefPubMedPubMedCentral
Roche F, Sforza E, Pichot V, Maudoux D, Garcin A, Celle S, Picard-Kossovsky M, Gaspoz JM, Barthelemy JC, Group PS (2009) Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med 10(8):882–886. https://doi.org/10.1016/j.sleep.2008.07.017 CrossRefPubMed
Gunduz C, Basoglu OK, Hedner J, Zou D, Bonsignore MR, Hein H, Staats R, Pataka A, Barbe F, Sliwinski P, Kent BD, Pepin JL, Grote L (2018) Obstructive sleep apnoea independently predicts lipid levels: data from the European Sleep Apnea Database. Respirology 23(12):1180–1189. https://doi.org/10.1111/resp.13372 CrossRefPubMed
Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, Rood JC, Burk DH, Smith SR (2009) Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 58(3):718–725. https://doi.org/10.2337/db08-1098 CrossRefPubMedPubMedCentral
Spiegel K, Leproult R, Van Cauter E (1999) Impact of sleep debt on metabolic and endocrine function. Lancet 354(9188):1435–1439. https://doi.org/10.1016/S0140-6736(99)01376-8 CrossRefPubMed
Appleton SL, Vakulin A, Martin SA, Lang CJ, Wittert GA, Taylor AW, McEvoy RD, Antic NA, Catcheside PG, Adams RJ (2016) Hypertension is associated with undiagnosed OSA during rapid eye movement sleep. Chest 150(3):495–505. https://doi.org/10.1016/j.chest.2016.03.010 CrossRefPubMed
Mokhlesi B, Hagen EW, Finn LA, Hla KM, Carter JR, Peppard PE (2015) Obstructive sleep apnoea during REM sleep and incident non-dipping of nocturnal blood pressure: a longitudinal analysis of the Wisconsin Sleep Cohort. Thorax 70(11):1062–1069. https://doi.org/10.1136/thoraxjnl-2015-207231 CrossRefPubMed
Lin CY, Ho CS, Tsai WC, Chen JY (2018) Different effects of apnea during rapid eye movement period on peripheral arterial stiffness in obstructive sleep apnea. Atherosclerosis 269:166–171. https://doi.org/10.1016/j.atherosclerosis.2018.01.008 CrossRefPubMed
Grimaldi D, Beccuti G, Touma C, Van Cauter E, Mokhlesi B (2014) Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications. Diabetes Care 37(2):355–363. https://doi.org/10.2337/dc13-0933 CrossRefPubMedPubMedCentral
Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-Chiong T, Loube DL, Owens J, Pancer JP, Wise M (2005) Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28(4):499–521 CrossRefPubMed
Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Davidson Ward SL, Tangredi MM (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 8(5):597–619. https://doi.org/10.5664/jcsm.2172 CrossRefPubMedPubMedCentral
Mullington JM, Abbott SM, Carroll JE, Davis CJ, Dijk DJ, Dinges DF, Gehrman PR, Ginsburg GS, Gozal D, Haack M, Lim DC, Macrea M, Pack AI, Plante DT, Teske JA, Zee PC (2016) Developing biomarker arrays predicting sleep and circadian-coupled risks to health. Sleep 39(4):727–736. https://doi.org/10.5665/sleep.5616 CrossRefPubMedPubMedCentral
Drager LF, Jun J, Polotsky VY (2010) Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 17 (2):161–165. https://doi.org/10.1097/MED.0b013e3283373624 CrossRefPubMedPubMedCentral
Tan KC, Chow WS, Lam JC, Lam B, Wong WK, Tam S, Ip MS (2006) HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184(2):377–382. https://doi.org/10.1016/j.atherosclerosis.2005.04.024 CrossRefPubMed
Wolk R, Shamsuzzaman AS, Somers VK (2003) Obesity, sleep apnea, and hypertension. Hypertension 42(6):1067–1074. https://doi.org/10.1161/01.HYP.0000101686.98973.A3 CrossRefPubMed
Gaines J, Vgontzas AN, Fernandez-Mendoza J, Bixler EO (2018) Obstructive sleep apnea and the metabolic syndrome: the road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment. Sleep Med Rev 42:211–219. https://doi.org/10.1016/j.smrv.2018.08.009 CrossRefPubMed
Jullian-Desayes I, Joyeux-Faure M, Tamisier R, Launois S, Borel AL, Levy P, Pepin JL (2015) Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials. Sleep Med Rev 21:23–38. https://doi.org/10.1016/j.smrv.2014.07.004 CrossRefPubMed
Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson BA (1993) Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb Vasc Biol 13(2):296–301 CrossRef
Pucci E, Chiovato L, Pinchera A (2000) Thyroid and lipid metabolism. Int J Obes 24(S2):S109–S112 CrossRef
Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R (2008) Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 134(4):686–692. https://doi.org/10.1378/chest.08-0556 CrossRefPubMed
- Association Between Serum Lipid Profile and Obstructive Respiratory Events During REM and Non-REM Sleep
David Laszlo Tarnoki
Adam Domonkos Tarnoki
- Springer US
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II